US Drugs Manufacturer Merck Dissaproves Using Anti-Parasite Drugs to Treat Covid-19
An analytical study by Merck & Co revealed the use of Ivermectin to treat Covid-19 does not pass safety and
Read more
Merck & Co
Merck & Co. (NYSE:MRK)Signs $356 Million Deal for Supply of Its COVID-19 Treatment in the US
Merck & Co. (NYSE:MRK) has signed a $356 million supply deal with the US government for the supply of 60,000
Read more